pISSN 2636-0004
eISSN 2636-0012

Table. 2.

Perioperative Outcomes of Robotic Pancreatoduodenectomy Compared to Open or Laparoscopic Pancreatoduodenectomy

Author (yr) Number Operation time (min) Estimated blood loss (mL) Intraoperative transfusion, n (%) Major vessel resection*, n (%) Open conversion,
n (%)
POPF,
n (%)
Major morbidity, n (%) LOS
(day)
Kim et al (2022)25 RPD (328)
OPD (656)
339
290
417
470
40 (12.2)
81 (12.3)
NA
NA
NA
NA
32 (9.8)
73 (11.1)
56 (17.1)
120 (18.3)
10.8
15.6
Shyr et al (2022)26 RPD (65)
OPD (65)
498
420
251
562
NA
NA
9 (13.8)
11 (16.9)
NA
NA
6 (9.2)
2 (4.6)
4 (6.2)
4 (6.2)
NA
NA
Weng et al (2021)27 RPD (105)
OPD (210)
300
300
300
300
NA
NA
9 (8.6)
20 (9.5)
2 (1.8)
NA
6 (5.7)
14 (6.7)
NA
NA
17
17
Kim et al (2022)28 RPD (74)
LPD (74)
412
453
NA
NA
5 (6.8)
4 (5.4)
NA
NA
0 (0.0)
6 (8.1)
9 (12.2)
10 (13.5)
16 (21.6)
11 (14.9)
11.9
14.6
van Oosten et al (2021)29 RPD (90)
LPD (90)
471
445
125
300
1 (1.1)
11 (12.2)
NA
NA
NA
NA
9 (10.0)
4 (4.4)
NA
NA
8
8

POPF, postoperative pancreatic fistula; LOS, length of hospital stay after operation; RPD, robotic pancreatoduodenectomy; OPD, open pancreatoduodenectomy; NA, not available; LPD, laparoscopic pancreatoduodenectomy.

*Major vessel resection was defined as resection of the superior mesenteric vein, portal vein, hepatic artery, or superior mesenteric artery during operation.

†Major morbidity was defined as a Clavien-Dindo classification grade IIIa or above.

‡A statistically significant difference existed between two groups.

Int J Gastrointest Interv 2022;11:64~69 https://doi.org/10.18528/ijgii220011
© Int J Gastrointest Interv